These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 23159154)

  • 1. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription-polymerase chain reaction in formalin-fixed, paraffin-embedded tumor.
    Isphording A; Ali RH; Irving J; Goytain A; Nelnyk N; Hoang LN; Gilks CB; Huntsman DG; Nielsen TO; Nucci MR; Lee CH
    Hum Pathol; 2013 May; 44(5):837-43. PubMed ID: 23159154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel, recurrent MBTD1-CXorf67 fusion in low-grade endometrial stromal sarcoma.
    Dewaele B; Przybyl J; Quattrone A; Finalet Ferreiro J; Vanspauwen V; Geerdens E; Gianfelici V; Kalender Z; Wozniak A; Moerman P; Sciot R; Croce S; Amant F; Vandenberghe P; Cools J; Debiec-Rychter M
    Int J Cancer; 2014 Mar; 134(5):1112-22. PubMed ID: 23959973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinicopathologic features of YWHAE-FAM22 endometrial stromal sarcomas: a histologically high-grade and clinically aggressive tumor.
    Lee CH; Mariño-Enriquez A; Ou W; Zhu M; Ali RH; Chiang S; Amant F; Gilks CB; van de Rijn M; Oliva E; Debiec-Rychter M; Dal Cin P; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 May; 36(5):641-53. PubMed ID: 22456610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement.
    Lee CH; Ali RH; Rouzbahman M; Marino-Enriquez A; Zhu M; Guo X; Brunner AL; Chiang S; Leung S; Nelnyk N; Huntsman DG; Blake Gilks C; Nielsen TO; Dal Cin P; van de Rijn M; Oliva E; Fletcher JA; Nucci MR
    Am J Surg Pathol; 2012 Oct; 36(10):1562-70. PubMed ID: 22982899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The application of next-generation sequencing-based molecular diagnostics in endometrial stromal sarcoma.
    Li X; Anand M; Haimes JD; Manoj N; Berlin AM; Kudlow BA; Nucci MR; Ng TL; Stewart CJ; Lee CH
    Histopathology; 2016 Oct; 69(4):551-9. PubMed ID: 26990025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endometrial stromal sarcoma: morphologic features and detection of JAZF1-SUZ12 and YWHAE FAM22 fusion genes].
    Chang B; Lu LX; Tu XY; Cheng YF; Bi R; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2016 May; 45(5):308-13. PubMed ID: 27142911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YWHAE rearrangement identified by FISH and RT-PCR in endometrial stromal sarcomas: genetic and pathological correlations.
    Croce S; Hostein I; Ribeiro A; Garbay D; Velasco V; Stoeckle E; Guyon F; Floquet A; Neuville A; Coindre JM; MacGrogan G; Chibon F
    Mod Pathol; 2013 Oct; 26(10):1390-400. PubMed ID: 23599159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait.
    Ali RH; Al-Safi R; Al-Waheeb S; John B; Al-Ali W; Al-Jassar W; Al-Mulla F; Melnyk N; Huntsman DG; Lee CH
    Hum Pathol; 2014 Dec; 45(12):2453-62. PubMed ID: 25288234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 14-3-3 fusion oncogenes in high-grade endometrial stromal sarcoma.
    Lee CH; Ou WB; Mariño-Enriquez A; Zhu M; Mayeda M; Wang Y; Guo X; Brunner AL; Amant F; French CA; West RB; McAlpine JN; Gilks CB; Yaffe MB; Prentice LM; McPherson A; Jones SJ; Marra MA; Shah SP; van de Rijn M; Huntsman DG; Dal Cin P; Debiec-Rychter M; Nucci MR; Fletcher JA
    Proc Natl Acad Sci U S A; 2012 Jan; 109(3):929-34. PubMed ID: 22223660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.
    Kruse AJ; Croce S; Kruitwagen RF; Riedl RG; Slangen BF; Van Gorp T; Van de Vijver KK
    Int J Gynecol Cancer; 2014 Nov; 24(9):1616-22. PubMed ID: 25244606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JAZF1/JJAZ1 gene fusion in endometrial stromal sarcomas: molecular analysis by reverse transcriptase-polymerase chain reaction optimized for paraffin-embedded tissue.
    Hrzenjak A; Moinfar F; Tavassoli FA; Strohmeier B; Kremser ML; Zatloukal K; Denk H
    J Mol Diagn; 2005 Aug; 7(3):388-95. PubMed ID: 16049311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel EPC1 gene fusions in endometrial stromal sarcoma.
    Dickson BC; Lum A; Swanson D; Bernardini MQ; Colgan TJ; Shaw PA; Yip S; Lee CH
    Genes Chromosomes Cancer; 2018 Nov; 57(11):598-603. PubMed ID: 30144186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features.
    Sciallis AP; Bedroske PP; Schoolmeester JK; Sukov WR; Keeney GL; Hodge JC; Bell DA
    Am J Surg Pathol; 2014 Sep; 38(9):1161-72. PubMed ID: 25133706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.
    Chiang S; Lee CH; Stewart CJR; Oliva E; Hoang LN; Ali RH; Hensley ML; Arias-Stella JA; Frosina D; Jungbluth AA; Benayed R; Ladanyi M; Hameed M; Wang L; Kao YC; Antonescu CR; Soslow RA
    Mod Pathol; 2017 Sep; 30(9):1251-1261. PubMed ID: 28621321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEAF6/PHF1 is a recurrent gene fusion in endometrial stromal sarcoma.
    Micci F; Gorunova L; Gatius S; Matias-Guiu X; Davidson B; Heim S; Panagopoulos I
    Cancer Lett; 2014 May; 347(1):75-8. PubMed ID: 24530230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular detection of JAZF1-JJAZ1 gene fusion in endometrial stromal neoplasms with classic and variant histology: evidence for genetic heterogeneity.
    Huang HY; Ladanyi M; Soslow RA
    Am J Surg Pathol; 2004 Feb; 28(2):224-32. PubMed ID: 15043312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancies in pathological diagnosis of endometrial stromal sarcoma: a multi-institutional retrospective study from the Japanese clinical oncology group.
    Yoshida H; Kikuchi A; Tsuda H; Sakamoto A; Fukunaga M; Kaku T; Yoshida M; Shikama A; Kogata Y; Terao Y; Tanikawa M; Yasuoka T; Chiyoda T; Miyamoto T; Okadome M; Nakamura T; Enomoto T; Konno Y; Yahata H; Hirata Y; Aoki Y; Tokunaga H; Usui H; Yaegashi N
    Hum Pathol; 2022 Jun; 124():24-35. PubMed ID: 35339567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance characteristics of a reverse transcriptase-polymerase chain reaction assay for the detection of tumor-specific fusion transcripts from archival tissue.
    Fritsch MK; Bridge JA; Schuster AE; Perlman EJ; Argani P
    Pediatr Dev Pathol; 2003; 6(1):43-53. PubMed ID: 12375129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interphase cytogenetic study of endometrial stromal sarcoma by chromosome in situ hybridization.
    Cheung AN; Tin VP; Ngan HY; Chung LP; Khoo US
    Mod Pathol; 1996 Sep; 9(9):910-8. PubMed ID: 8878023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.